Hybrid insulin cocrystals for controlled release delivery (Q44074369)

29 November 2017

title

Hybrid insulin cocrystals for controlled release delivery (English)

1 reference

29 November 2017

1 reference

1 reference

Mark L Brader

1 reference

29 November 2017

Muppalla Sukumar

1 reference

29 November 2017

Allen H Pekar

1 reference

29 November 2017

David S McClellan

1 reference

29 November 2017

Ronald E Chance

1 reference

29 November 2017

David B Flora

1 reference

29 November 2017

Amy L Cox

1 reference

29 November 2017

Lynnie Irwin

1 reference

29 November 2017

Sharon R Myers

1 reference

29 November 2017

publication date

22 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

page(s)

800-804

1 reference

New methods of drug delivery

29 November 2017

cites work

1 reference

Improving protein therapeutics with sustained-release formulations

21 January 2018

1 reference

Landmark perspective: Protamine insulin. Hagedorn's pioneering contribution to drug delivery in the management of diabetes

21 January 2018

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

Improving insulin therapy: achievements and challenges

21 January 2018

1 reference

Insulins today and beyond

21 January 2018

1 reference

Crystal structure of a prolonged-acting insulin with albumin-binding properties

21 January 2018

1 reference

Mechanism of protracted metabolic effects of fatty acid acylated insulin, NN304, in dogs: retention of NN304 by albumin

21 January 2018

1 reference

Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo

21 January 2018

1 reference

21 January 2018

1 reference

X-ray diffraction data on some crystalline varieties of insulin

21 January 2018

1 reference

X-ray crystallographic studies on hexameric insulins in the presence of helix-stabilizing agents, thiocyanate, methylparaben, and phenol

21 January 2018

1 reference

Altering the association properties of insulin by amino acid replacement

21 January 2018

1 reference

Structural and morphological characterization of ultralente insulin crystals by atomic force microscopy: evidence of hydrophobically driven assembly

21 January 2018

1 reference

The lifetime of insulin hexamers

21 January 2018

1 reference

Diamonds in the rough: protein crystals from a formulation perspective

21 January 2018

1 reference

High-throughput protein crystallization

21 January 2018

1 reference

Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer

21 January 2018

1 reference

Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue

21 January 2018

1 reference

Basal activity profiles of NPH and [Nepsilon-palmitoyl Lys (B29)] human insulins in subjects with IDDM

21 January 2018

1 reference

Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304

21 January 2018

1 reference

Cocrystallization of proinsulin and insulin

21 January 2018

1 reference

Structure of porcine insulin cocrystallized with clupeine Z

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Acylation of human insulin with palmitic acid extends the time action of human insulin in diabetic dogs

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NBT722

1 reference

29 November 2017

1 reference